Share on Pinterest Recent anecdotal reports have highlighted strange side effects of GLP-1 medications used for weight loss like “Ozempic ... health lowering kidney disease risk improving ...

Ozempic and Wegovy have taken the back seat.

Ozempic is already approved to treat T2D, for cardiovascular risk reduction ... worsening kidney disease and cardiovascular death in people with T2D and CKD. …as Rybelsus cuts MACE in type ...

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...

WHEN Aimee Chapman began using fat jabs just over a year ago, she never expected to end up in hospital fighting for her life, ...

Semaglutide cut inflammation in two thirds of patients with non-alcoholic fatty liver disease. The medicine is used in weight-loss injection Wegovy and diabetes treatment Ozempic. Fatty liver ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

“With its expected benefit-risk profile ... that its Wegovy and Ozempic drugs – both based on GLP-1 agonist semaglutide – can reduce cardiovascular and kidney disease outcomes, respectively ...

Heart disease can be a killer ... with it - from strokes and heart attacks to kidney and liver problems. According to the British Heart Foundation risk factors include having high blood pressure ...

The popularity of cottage cheese recipes, protein powders, and even Khloé Kardashian's popcorn launch prove a shift toward a ...

Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...